School-based Asthma Care for Teens (SB-ACT)
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 12 - 16 |
| Updated: | 4/6/2019 |
| Start Date: | July 2014 |
| End Date: | June 2021 |
The goal of this study is to evaluate the widespread implementation of a developmentally
appropriate preventive asthma care intervention for urban teens. The School Based Asthma Care
for Teens (SB-ACT) program includes two core components: 1) a trial of directly observed
therapy (DOT) to allow the teen to experience the potential benefits from adhering to
guideline-based asthma treatment, and 2) a developmentally appropriate Motivational
Interviewing (MI) Counseling Intervention to help the teen transition to independent
long-term medication adherence. The investigators hypothesize that teens receiving the SB-ACT
program will 1) experience less asthma-related morbidity than an asthma education (AE)
attention-control comparison group, and 2) have improved adherence, less urgent healthcare
use, less absenteeism, improved quality of life, and reduced FeNO compared to AE. The
investigators also hypothesize that participants receiving DOT-only will have improved
asthma-related outcomes immediately following their DOT trial vs. teens receiving AE, but
will not have sustained, clinically significant improvement in outcomes once the DOT phase is
complete. This represents a unique opportunity to build upon existing community relationships
with an innovative and developmentally focused program to improve asthma outcomes for urban
teens.
appropriate preventive asthma care intervention for urban teens. The School Based Asthma Care
for Teens (SB-ACT) program includes two core components: 1) a trial of directly observed
therapy (DOT) to allow the teen to experience the potential benefits from adhering to
guideline-based asthma treatment, and 2) a developmentally appropriate Motivational
Interviewing (MI) Counseling Intervention to help the teen transition to independent
long-term medication adherence. The investigators hypothesize that teens receiving the SB-ACT
program will 1) experience less asthma-related morbidity than an asthma education (AE)
attention-control comparison group, and 2) have improved adherence, less urgent healthcare
use, less absenteeism, improved quality of life, and reduced FeNO compared to AE. The
investigators also hypothesize that participants receiving DOT-only will have improved
asthma-related outcomes immediately following their DOT trial vs. teens receiving AE, but
will not have sustained, clinically significant improvement in outcomes once the DOT phase is
complete. This represents a unique opportunity to build upon existing community relationships
with an innovative and developmentally focused program to improve asthma outcomes for urban
teens.
Inclusion Criteria:
- Physician-diagnosed asthma
- Persistent asthma or poor asthma control (based on NHLBI guidelines).
- Attending secondary school in Rochester City School District
Exclusion Criteria:
- Inability to speak and understand English
- No access to a phone for follow-up surveys
- Diagnosed developmental or intellectual disability
- Other significant medical conditions, including congenital heart disease, cystic
fibrosis, or other chronic lung disease, that could interfere with the assessment of
asthma-related measures.
- Teens in foster care or other situations in which consent cannot be obtained from a
guardian.
We found this trial at
1
site
60 Crittenden Blvd # 70
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Jill S Halterman, MD, MPH
Phone: 585-275-6954
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
